Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 8Neoplasms 3Esophageal Neoplasms 2Stomach Neoplasms 1Platelet Glycoprotein IV Deficiency 1Pancreatic Intraductal Neoplasms 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Cyst 1Neoplasm Metastasis 1Leiomyoma 1Jaundice, Obstructive 1Gastrointestinal Stromal Tumors 1Fatty Liver 1Disease 1Cysts 1Colonic Neoplasms 1Carcinoma, Pancreatic Ductal 1Adrenal Gland Neoplasms 1Adrenal Gland Diseases 1Adenocarcinoma 1

Interventions

Gemcitabine 2selinexor 1ponatinib 1neratinib 1folfirinox 1contrast agent BR1 1cobimetinib 1ceritinib 1brigatinib 1abemaciclib 1Urination 1S 1 (combination) 1Radiotherapy 1Radiosurgery 1Practice Guidelines as Topic 1Pancreaticoduodenectomy 1Paclitaxel 1Oxaliplatin 1Long Interspersed Nucleotide Elements 1Laparoscopy 1Irinotecan 1Immunotherapy, Adoptive 1Floxuridine 1Etoposide 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1Doxorubicin 1Colchicine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Pancreatic Ductal × Endosonography × Clear all
NCT05621824 2024-04-09

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

Peking Union Medical College Hospital

Not yet recruiting
900 enrolled
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡